These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22166446)

  • 1. Patterns of α-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease.
    van de Berg WD; Hepp DH; Dijkstra AA; Rozemuller JA; Berendse HW; Foncke E
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S28-30. PubMed ID: 22166446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.
    Dijkstra AA; Voorn P; Berendse HW; Groenewegen HJ; ; Rozemuller AJ; van de Berg WD
    Mov Disord; 2014 Sep; 29(10):1244-51. PubMed ID: 24996051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model.
    Kingsbury AE; Bandopadhyay R; Silveira-Moriyama L; Ayling H; Kallis C; Sterlacci W; Maeir H; Poewe W; Lees AJ
    Mov Disord; 2010 Nov; 25(15):2508-15. PubMed ID: 20818670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinico-pathological study of subtypes in Parkinson's disease.
    Selikhova M; Williams DR; Kempster PA; Holton JL; Revesz T; Lees AJ
    Brain; 2009 Nov; 132(Pt 11):2947-57. PubMed ID: 19759203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Parkinson's disease pathology be propagated from one neuron to another?
    Dunning CJ; Reyes JF; Steiner JA; Brundin P
    Prog Neurobiol; 2012 May; 97(2):205-19. PubMed ID: 22115849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
    Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progression of pathology in Parkinson's disease.
    Halliday GM; McCann H
    Ann N Y Acad Sci; 2010 Jan; 1184():188-95. PubMed ID: 20146698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralaminar nuclei of the thalamus in Lewy body diseases.
    Brooks D; Halliday GM
    Brain Res Bull; 2009 Feb; 78(2-3):97-104. PubMed ID: 18804518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synucleinopathies from bench to bedside.
    Puschmann A; Bhidayasiri R; Weiner WJ
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S24-7. PubMed ID: 22166445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein in the olfactory system in Parkinson's disease: role of neural connections on spreading pathology.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Martinez-Marcos A
    Brain Struct Funct; 2014 Sep; 219(5):1513-26. PubMed ID: 24135772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversy: is Parkinson's disease a single disease entity? Yes.
    Takahashi H; Wakabayashi K
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Course in Parkinson disease subtypes: A 39-year clinicopathologic study.
    Rajput AH; Voll A; Rajput ML; Robinson CA; Rajput A
    Neurology; 2009 Jul; 73(3):206-12. PubMed ID: 19620608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
    Hansen C; Li JY
    Trends Mol Med; 2012 May; 18(5):248-55. PubMed ID: 22503115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic involvement in Parkinson's disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers.
    Cersosimo MG; Benarroch EE
    J Neurol Sci; 2012 Feb; 313(1-2):57-63. PubMed ID: 22001247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.